| Autor: |
Louie JK; California Emerging Infections Program, California Department of Health Services, Berkeley, 94704, USA. JLouie@dhs.ca.gov, Hacker JK, Mark J, Gavali SS, Yagi S, Espinosa A, Schnurr DP, Cossen CK, Isaacson ER, Glaser CA, Fischer M, Reingold AL, Vugia DJ |
| Jazyk: |
angličtina |
| Zdroj: |
Emerging infectious diseases [Emerg Infect Dis] 2004 Jun; Vol. 10 (6), pp. 1143-6. |
| DOI: |
10.3201/eid1006.030863 |
| Abstrakt: |
In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspected SARS and 9 (47%) of 19 patients with probable SARS. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
